Cyclerion Therapeutics, Inc.
Developing personalized therapy for TRD with a biofeedback device and anesthetics.
CYCN | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 301 BINNEY STREET, 2142 CAMBRIDGE
- Website:
- https://www.cyclerion.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing personalized treatments for neuropsychiatric disorders. Following a strategic relaunch, the company's lead program is pioneering an individualized therapeutic approach for Treatment-Resistant Depression (TRD). This innovative method combines the use of generic anesthetics with a proprietary, biofeedback-driven medical device. The treatment is designed to reset dysregulated brainwave patterns in patients who have not responded to traditional therapies. Cyclerion's mission is to offer a safer and more effective treatment alternative for patients, healthcare providers, and hospitals in the mental health sector.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cyclerion Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cyclerion Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cyclerion Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
